LATN

Third Quarter 2021 Net Revenues Increased 35% to $106.8 Million Year-Over-Year with Adjusted EBITDA Up 27% Year-Over-Year to $24.5 Million First Nine Months Net Revenues Increased 33% to $283.2 Million, with LTM Net Revenues at $401.4 Million and LTM Adjusted EBITDA up to $100.3 Million Strong Double Digit Revenue Growth in Four Out of Five Business Units Driven by Market Share Gains and New Product Launches Closed Business Combination with Union Acquisition Corp. II on September 29, 2021, and Listed on The Nasdaq Global Market Under "PROC" on September 30, 2021 As a Result of the Business Combination, Procaps Group Ended the Third Quarter 2021 with $100.2 Million in Unrestricted Cash a

15-12B - Union Acquisition Corp. II (0001766146) (Filer)

8-K - Union Acquisition Corp. II (0001766146) (Filer)

5 - Union Acquisition Corp. II (0001766146) (Issuer)

4 - Union Acquisition Corp. II (0001766146) (Issuer)

8-K - Union Acquisition Corp. II (0001766146) (Filer)

25-NSE - Union Acquisition Corp. II (0001766146) (Subject)

Combined Company to Begin Trading on the Nasdaq Global Market® Under "PROC" and "PROCW" On September 30, 2021 Approximately $160 Million of Gross Proceeds Strategically Positions Procaps, a Leading Global Pharmaceutical Technology and Healthcare Company Based in Latin America, to Accelerate M&A Roll-Up Initiative and Expand New Product Categories in B2B & B2C Segments Strong First Half 2021 Financial Results Position Procaps to Achieve Prior Full Year 2021 Guidance of Approximately $400 Million in Net Revenues and $105 Million of Adjusted EBITDA Procaps Will be Led by Ruben Minski, Founder, Chairman of the Board and Chief Executive Officer of Procaps Group, and Current Executive Team Inc

4 - Union Acquisition Corp. II (0001766146) (Issuer)

425 - Union Acquisition Corp. II (0001766146) (Subject)

8-K - Union Acquisition Corp. II (0001766146) (Filer)

Union Acquisition Corp. II ("LATN") Shareholders Approve the Proposed Business Combination with Procaps Group and the Parties Agree to Close by September 30, 2021 Following the Closing of the Business Combination the Combined Company is expected to Trade on the Nasdaq Global Market® Under "PROC" and "PROCW" Union Acquisition Corp. II (NASDAQ:LATN, LATNU, LATNW))) ("LATN"), a publicly-traded special purpose acquisition company, announced today that its shareholders voted to approve the previously announced business combination (the "Business Combination") with Procaps Group, a leading integrated international healthcare and pharmaceutical company, and all other proposals presented at LATN'

425 - Union Acquisition Corp. II (0001766146) (Subject)

8-K - Union Acquisition Corp. II (0001766146) (Filer)

425 - Union Acquisition Corp. II (0001766146) (Filed by)

SC 13G/A - Union Acquisition Corp. II (0001766146) (Subject)

425 - Union Acquisition Corp. II (0001766146) (Filed by)

Strong Financial Performance Enables Procaps Group to Launch Private Placement of Senior Notes to Refinance Existing Debt with New Institutional Investors Utilizing a Lower Cost of Capital & Expanded Duration to Accelerate Growth Strategy Procaps Group (as defined below), a leading integrated international healthcare and pharmaceutical company, today announced that it has launched a private offering of an aggregate principal amount of U.S. $115 million of senior notes (the "Senior Notes") of Procaps, S.A. ("Procaps"), a subsidiary of Procaps Group, in a private placement transaction led by Prudential Private Capital, to entities including one or more investment funds or managed accounts of

SC 13G - Union Acquisition Corp. II (0001766146) (Subject)

425 - Union Acquisition Corp. II (0001766146) (Filed by)

Extraordinary General Meeting of Union Acquisition Corp. II ("LATN") Shareholders to Approve the Proposed Business Combination with Procaps Group Will be Held on September 22, 2021, at 9:00 a.m. ET. Shareholders, as of the Close of Business on the Record Date of August 19, 2021, Are Encouraged to Vote Their Shares. LATN's Board of Directors Recommends Shareholders Vote "FOR" All of the Proposals at the Extraordinary General Meeting. For More Information, LATN's Shareholders Are Encouraged to Carefully Read the Entire Definitive Proxy Statement Filed in Connection with the Proposed Business Combination. Procaps Group, a leading integrated international healthcare and pharmaceutical compa

DEFM14A - Union Acquisition Corp. II (0001766146) (Filer)

425 - Union Acquisition Corp. II (0001766146) (Filed by)

425 - Union Acquisition Corp. II (0001766146) (Filed by)

Procaps Group, a leading integrated international healthcare and pharmaceutical company, announced that in conjunction with Procaps Group's recent virtual analyst day and second quarter 2021 earnings results, it has released two new videos showcasing its Manufacturing and Research & Development facilities across Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210823005193/en/ The videos take viewers behind the scenes of its facilities for a look at production lines for their oral solutions and other over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potency clinical solutions. Please cli